The impact of renal function on efficacy and safety of new oral anticoagulant in atrial fibrillation patients
Author:
Publisher
Ovid Technologies (Wolters Kluwer Health)
Subject
General Medicine
Reference33 articles.
1. Prevalence of chronic kidney disease in the United States;Coresh;JAMA,2007
2. Prevention of stroke and systemic embolism with rivaroxaban compared with warfarin in patients with non-valvular atrial fibrillation and moderate renal impairment;Fox;Eur Heart J,2011
3. Guidelines for the management of atrial fibrillation: the Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology (ESC);Camm;Eur Heart J,2010
4. A novel user-friendly score (HAS-BLED) to assess 1-year risk of major bleeding in patients with atrial fibrillation: the Euro Heart Survey;Pisters;Chest,2010
5. Quality of care for atrial fibrillation among patients hospitalized for heart failure;Piccini;J Am Coll Cardiol,2009
Cited by 9 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Selection of Non-vitamin K Antagonist Oral Anticoagulant for Stroke Prevention in Atrial Fibrillation Based on Patient Profile: Perspectives from Vietnamese Experts. Part 2;European Cardiology Review;2023-12-15
2. The impact of anticoagulation therapy on kidney function in patients with atrial fibrillation and chronic kidney disease;Expert Review of Cardiovascular Therapy;2023-10-18
3. Kidney Function and the Use of Vitamin K Antagonists or Direct Oral Anticoagulants in Atrial Fibrillation;Journal of Cardiovascular Emergencies;2023-09-01
4. Comparing the Efficacy and Safety of Apixaban Versus Warfarin in Morbidly Obese Patients;Cureus;2022-10-14
5. New oral anticoagulants in nonvalvular atrial fibrillation;Galenika Medical Journal;2022
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3